Harvard, MIT Win CRISPR Patent Dispute Against Berkeley
For more crisp and insightful business and economic news, subscribe to The Daily Upside newsletter. It's completely free and we guarantee you'll learn something new every day.
Imagine winning a Nobel Prize for something and then your institution loses the patent rights. This researcher's greatest nightmare became reality at the University of California, Berkeley this week.
A battle of academic titans over one of the most potentially groundbreaking medical technologies in history ended with Harvard and MIT declared the owners of the patent for CRISPR gene editing. Berkeley, whose professor won the 2020 Nobel Prize in chemistry for her work on the technology, can't license it anymore.
Source Fool.com
